WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CADL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$37.9M
Current Profit Margin
0%

CADL Return on Equity

Current Company
-142.9%
Current Industry
-63.5%
Current Market
188%
CADL's Return on Equity (-142.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CADL announces earnings.

CADL Return on Assets

Current Company
-69.9%
Current Industry
2.9%
CADL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CADL Return on Capital Employed

Current Company
-130.82%
Current Industry
19.5%
CADL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CADL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CADL$0.00-$34.14M-$37.94MN/AN/A
CYBN$0.00-$51.93M-$52.19MN/AN/A
INMB$155.00k-$30.01M-$30.01M+235.68%N/A
ACHV$0.00-$26.73M-$29.82MN/AN/A
IMAB$3.84MN/A-$203.57M-12.91%N/A
View Top Biotech Stocks

CADL earnings dates

Next earnings date
May 9, 2024

Candel Therapeutics Earnings & Revenue FAQ

What were CADL's earnings last quarter?

On Invalid Date, Candel Therapeutics (NASDAQ: CADL) reported Q4 2023 earnings per share (EPS) of -$0.38, up 123.53% year over year. Total Candel Therapeutics earnings for the quarter were -$11.10 million. In the same quarter last year, Candel Therapeutics's earnings per share (EPS) was -$0.17.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.

What was CADL's earnings growth in the past year?

As of Q2 2024, Candel Therapeutics's earnings has grown year over year. Candel Therapeutics's earnings in the past year totalled -$37.94 million.

What is CADL's earnings date?

Candel Therapeutics's earnings date is Invalid Date. Add CADL to your watchlist to be reminded of CADL's next earnings announcement.

What was CADL's revenue last quarter?

On Invalid Date, Candel Therapeutics (NASDAQ: CADL) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Candel Therapeutics's revenue was $0.00.

What was CADL's revenue growth in the past year?

As of Q2 2024, Candel Therapeutics's revenue has grown null year over year. Candel Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.